Newsroom

Home / Newsroom

As the principal national public voice for ophthalmology in Canada, the Canadian Ophthalmological Society (COS) plays a critical role in advocating for optimal eye care for all Canadians.

Representing eye physicians and surgeons from coast to coast, COS strategically collaborates with governments, industry partners and health care allies on a wide range of advocacy issues, including stronger vision standards, improved federal regulations, and shorter wait times for speciality eye surgeries.

Wednesday October 14, 2020

Report provides 20/20 vision on value of ophthalmology in Canada

Report provides 20/20 vision on value of ophthalmology in Canada New report reveals projected cost savings of $1.6 billion in direct health care costs of treating vision loss OTTAWA, October 8, 2020 — Nearly 1 in 6 Canadians are living with one of the four major eye diseases and are at serious risk of losing […]

Tuesday September 1, 2020

May is National Vision Health Month

“The Canadian Opthalmological Society launched their first public awareness campaign, “See the Possibilities” in honour of National Vision Health month.” Jewel

Thursday April 11, 2019

MD financial management, in collaboration with Scotiabank, announces funding program to address clinician burnout

$625,000 investment will support the health and wellness ofCanadian physicians across the country MD Financial Management Inc., in collaboration with Scotiabank and the Canadian Medical Association, is proud to announce a $625,000 contribution to target the pressing issue of professional burnout among Canadian physicians. Physician health and wellness are critical to the long-term sustainability of […]

Thursday March 28, 2019

Wait Times web tool updated with latest data

The Canadian Institute for Health Information (CIHI) has released updated data on wait times for priority procedures in Canada. The data shows that approximately 30% of patients who required a hip or knee replacement or cataract surgery did not have their procedure done within the recommended wait times. The data also reveals that most Canadians […]

Tuesday March 19, 2019

MIGS – summarizing the evidence

Across Canada, there has been a growing demand for and use of MIGS. However, the direct and indirect costs of MIGS can be considerable, and coverage under the public health insurance plans is inconsistent across jurisdictions. Therefore, the aim of the health technology assessment (HTA) was to inform the optimal use, including appropriate patient selection […]

Friday March 8, 2019

Recommendations on the optimal use of minimally invasive glaucoma surgery

These recommendations were developed by the Health Technology Expert Review Panel (HTERP) based on evidence reviewed in a CADTH Health Technology Assessment (HTA) report. The HTA included a review of the clinical effectiveness and safety, costeffectiveness, patients’ and caregivers’ perspectives and experiences, ethical issues, and implementation issues regarding minimally invasive glaucoma surgery (MIGS) for the […]